https://scholars.lib.ntu.edu.tw/handle/123456789/633529
標題: | Biomarker Data from the Phase III KATHERINE Study of Adjuvant T-DM1 versus Trastuzumab for Residual Invasive Disease after Neoadjuvant Therapy for HER2-Positive Breast Cancer | 作者: | Denkert, Carsten Lambertini, Chiara Fasching, Peter A Pogue-Geile, Katherine L Mano, Max S Untch, Michael Wolmark, Norman CHIUN-SHENG HUANG et al., |
公開日期: | 14-四月-2023 | 卷: | 29 | 期: | 8 | 來源出版物: | Clinical cancer research : an official journal of the American Association for Cancer Research | 摘要: | In KATHERINE, adjuvant T-DM1 reduced risk of disease recurrence or death by 50% compared with trastuzumab in patients with residual invasive breast cancer after neoadjuvant therapy (NAT) comprised of HER2-targeted therapy and chemotherapy. This analysis aimed to identify biomarkers of response and differences in biomarker expression before and after NAT. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/633529 | ISSN: | 10780432 | DOI: | 10.1158/1078-0432.CCR-22-1989 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。